Indeed, we believe that the TLM_CFM-F_OSM combination’s superior anti-cancer properties against NSCLC lung tumors are due to increased TGF-β and MMP-9 expression as well as increased CFM-F penetration into the tumors in this study. This evidence concerns the gene TGFB1 and non-small cell lung carcinoma.